This important award recognises the supplier thriving in KO Validation.

Many congratulations to Abcam, winners of the Supplier Succeeding in KO Validation Award for 2022!

Abcam recognises the importance of KO validation and has an in-house validation approach involving human haploid cell lines to test their antibodies, and western blotting to confirm results for specificity against the target.

Andy Chalmers, CEO and founder of CiteAb said: ‘Antibody validation is an incredibly important aspect of reproducible research, and something that CiteAb has a long standing interest in supporting. We wanted to reward the supplier thriving in this area, so congratulations again to Abcam. Their KO Validation portfolio really goes to demonstrate their commitment to raising global research standards.’

The criteria:   At CiteAb we have developed industry leading data collection technology that can identify and understand global reagent use from scientific publications. This data was thoroughly analysed to determine the supplier with the most KO validated antibody products.